Gerevich József, Bácskai Erika, Matuszka Balázs, Czobor Pál
Addiktologiai Kutató Intézet, Budapest, Hungary.
Psychiatr Hung. 2010;25(5):394-406.
The SCID-I structured clinical interview based on the DSM-IV-TR criteria is widely used in internationally, but the reliability and validity of its Hungarian version has not been investigated. This paper presents the results of the first validity and reliability study of the Hungarian version of the SCID-I/NP's (Structured Clinical Interview for DSM-IV-TR Axis I Disorders Non-patient Edition) Anxiety Disorders module.
The language adaptation of the diagnostic interview and of the user's guide was conducted in accordance with the WHO recommendations.
SCID-I/NP Overview and Screening module; SCID-I/NP Module F: Anxiety Disorders; Tests providing external validity: Beck Anxiety Inventory (BAI), Adult ADHD Self-Report Scale (ASRS), Buss-Perry Aggression Questionnaire (AQ), Alcohol Use Disorders Identification Test (AUDIT). The study sample consisted of 741 patients attended at three GP's offices. The trial's duration was two months.
GLM analysis, Chi-square test, Fisher's exact test, Kappa and weighted Kappa statistics.
Results showed a significant interrater-agreement between the rater pairs. For screening modules yealding negative results, the false-negative analysis indicated a subthreshold positive diagnosis in one case. External validity analyses showed significant discrepancies in terms of gender, marital status and past psychiatric treatments among the three sample groups including those with diagnosis present, subthreshold diagnosis, diagnosis absent. In terms of the psychometric scales, we found significant differences on the BAI and the ASRS in these groups. In the case of AQ we found significant differences in total score and in the factors of hostility and anger: the diagnosis present group showed significantly elevated severity values compared to the other two groups.
The Anxiety Disorders Module of the SCID-I/NP is suitable for detecting anxiety disorders in non-psychiatric population, and hence enables the early admission for treatment.
基于《精神疾病诊断与统计手册》第四版修订版（DSM-IV-TR）标准的SCID-I结构化临床访谈在国际上被广泛使用，但其匈牙利语版本的信度和效度尚未得到研究。本文呈现了SCID-I/NP（《精神疾病诊断与统计手册》第四版修订版轴I障碍非患者版结构化临床访谈）焦虑症模块匈牙利语版本首次效度和信度研究的结果。
诊断访谈和用户指南的语言改编按照世界卫生组织的建议进行。
SCID-I/NP概述与筛查模块；SCID-I/NP模块F：焦虑症；提供外部效度的测试：贝克焦虑量表（BAI）、成人注意力缺陷多动障碍自评量表（ASRS）、布斯-佩里攻击性问卷（AQ）、酒精使用障碍识别测试（AUDIT）。研究样本包括在三个全科医生诊所就诊的741名患者。试验持续时间为两个月。
广义线性模型分析、卡方检验、费舍尔精确检验、卡帕和加权卡帕统计。
结果显示评分者对之间存在显著的评分者间一致性。对于得出阴性结果的筛查模块，假阴性分析表明有一例存在阈下阳性诊断。外部效度分析显示，在包括有诊断、阈下诊断、无诊断的三个样本组之间，在性别、婚姻状况和过去的精神科治疗方面存在显著差异。在心理测量量表方面，我们发现这些组在BAI和ASRS上存在显著差异。在AQ方面，我们发现总分以及敌意和愤怒因子存在显著差异：有诊断组的严重程度值明显高于其他两组。
SCID-I/NP的焦虑症模块适用于在非精神科人群中检测焦虑症，从而能够实现早期入院治疗。
